Pharmacological strategies to selectively label and localize muscarinic receptor subtypes

Drug Development Research

Volumn 40, Issue 2, 1997, Pages 104-116

  Flynn, Donna D ^a   Reever, Carolyn M ^a   Ferrari DiLeo, Gaby ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

3H N methylscopolamine; 3H pirenzepine; Autoradiography; Binding brain

Indexed keywords

11 [[4 [4 (DIETHYLAMINO)BUTYL] 1 PIPERIDYL]ACETYL] 5,11 DIHYDRO 6H PYRIDO[2,3 B][1,4]BENZODIAZEPIN 6 ONE; 4 DIPHENYLACETOXY 1 METHYLPIPERIDINE; ATROPINE; DEXETIMIDE; HIMBACINE; METHOCTRAMINE; METHYLSCOPOLAMINE; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; N [2 [2 (DIPROPYLAMINOMETHYL) 1 PIPERIDYL]ETHYL] 5,11 DIHYDRO 6 OXO 6H PYRIDO[2,3 B][1,4]BENZODIAZEPINE 11 CARBOXAMIDE; OTENZEPAD; PIRENZEPINE; RECEPTOR PROTEIN; RECEPTOR SUBTYPE; TRIHEXYPHENIDYL; TRIPITRAMINE;

ANIMAL TISSUE; AUTORADIOGRAPHY; BINDING AFFINITY; BRAIN; BRAIN CORTEX; BRAIN REGION; BRAIN STEM; CHO CELL; CONTROLLED STUDY; CORPUS STRIATUM; DRUG DEVELOPMENT; HIPPOCAMPUS; IN VITRO STUDY; MOLECULAR CLONING; NONHUMAN; OLFACTORY BULB; PROPRIOCEPTION; RECEPTOR BINDING; REVIEW; SALIVARY GLAND; TECHNIQUE;

EID: 0030990069     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2299(199702)40:2<104::AID-DDR2>3.0.CO;2-P     Document Type: Review

References (66)

1. Adem A, Asblom A, Johansson G, Mbugua PM, Karlsson E (1988): Toxins from the venom of the green mamba Dendroaspis angusticeps that inhibit the binding of quinuclidinyl benzilate to muscarinic acetylcholine receptors. Biochm Biophys Acta 968:340-345.
2. Bonner TI, Buckley NJ, Young AC, Brann MR (1987): Identification of a family of muscarinic acetylcholine receptor genes. Science 237:527-532.
3. Bonner TI, Young AC, Brann MR, Buckley NJ (1988): Cloning and expression of the human and rat m5 muscarinic receptor genes. Neuron 1:403-410.
4. Brann MR, Jorgensen HB, Burstein ES, Spalding TA, Ellis J, Jones PSV, Hill-Eubanks D (1993): Studies of the pharmacology, localization, and structure of muscarinic acetylcholine receptors. Ann NY Acad Sci 707:225-236.
5. Bredt DS, Snyder SH (1992): Nitric oxide, a novel neuronal messenger. Neuron 8:3-11.
6. Buckley NJ, Bonner TI, Brann MR (1988): Localization of a family of muscarinic receptor mRNA's in rat brain. J Neurosci 8:4646-4652.
7. Buckley NJ, Bonner TI, Buckley CM, Brann MR (1989): Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells. Mol Pharmacol 35:469-476.
8. Caulfield MP (1993): Muscarinic receptors: characterization, coupling and function. Pharmacol Ther 58:319-379.
9. Delmendo RE, Michel AD, Whiting RL (1989): Affinity of muscarinic receptor antagonist for three putative muscarinic receptor binding sites. Br J Pharmacol 96:457-464.
10. Doods HN, Mathy M-J, Davidesko D, van Charldorp KJ, de Jonge A, van Zwieten PA (1987): Selectivity of muscarinic antagonists in radioligand and in vitro experiments for the putative M1, M2 and M3 receptors. J Pharmacol Exp Ther 242:257-262.
11. Dorje F, Levey AI, Brann MR (1991a): Immunological detection of muscarinic receptor subtype proteins (m1-m5) in rabbit peripheral tissues. Mol Pharmacol 40:459-462.
12. Dorje F, Wess J, Lambrecht G, Tacke R, Mutschler E, Brann MR (1991b): Antagonist binding profiles of five cloned human muscarinic receptor subtypes. J Pharmacol Exp Ther 256:727-733.
13. Eglen RM, Harris GC (1993): Selective inactivation of muscarinic M2 and M3 receptors in guinea-pig ileum and atria in vitro. Br J Pharmacol 109:946-952.
14. Eglen RM, Reddy H, Watson N (1994): Selective inactivation of muscarinic receptor subtypes. Int J Biochem 26:1357-1368.
15. Ferrari-DiLeo G, Flynn DD (1995): Characterization of muscarinic receptors on cultured microglial cells. Life Sci 56:1037.
16. Ferrari-DiLeo G, Waelbroeck M, Mash DC, Flynn DD (1994): Selective labeling and localization of the M4 (m4) muscarinic receptor subtype. Mol Pharmacol 46:1028-1035.
17. 3H]-N-methyl scopolamine afford differential labeling and localization of M1, M2 and M3 muscarinic receptor subtypes in primate brain. Synapse 14:283-296.
18. Flynn DD, Weinstein DA, Mash DC (1991): Loss of high-affinity agonist binding to M1 muscarinic receptors in Alzheimer's disease: implications for the failure of cholinergic replacement therapies. Ann Neurol 29:256-262.
19. Flynn DD, Ferrari-DiLeo G, Mash DC, Levey AI (1995): Differential regulation of molecular subtypes of muscarinic receptors in Alzheimer's disease. J Neurochem 64:1888-1891.
20. Gil DW, Wolfe BB (1985): Pirenzepine distinguishes between muscarinic receptor-mediated phosphoinositide breakdown and inhibition of adenylate cyclase. J Pharmacol Exp Ther 232:608-616.
21. Gonzalez RA, Crews FT (1984): Characterization of the cholinergic stimulation of phosphoinositide hydrolysis in rat brain slices. J Neurosci 4:4120-4127.
22. Hammer R, Berrie CP, Birdsall NJM, Burgen ASV, Hume EC (1980): Pirenzepine distinguishes between different subclasses of muscarinic receptors. Nature 283:90-92.
23. Hersch SM, Gutekunst C-A, Reese HD, Heilman CJ, Levey AI (1994): Distribution of m1-m4 muscarinic receptor proteins in the rat striatum: light and electron microscopic immunocytochemistry using subtype-specific antibodies. J Neurosci 14:3351-3363.
24. Jerusalinsky D, Harvey AL (1994): Toxins from mamba venoms: small proteins with selectivities for different subtypes of muscarinic acetylcholine receptors. Trends Pharmacol Sci 15:424-430.
25. Kemp JA, Leeson PD (1993): The glycine site of the NMDA receptor: five years on. Trends Pharmacol Sci 14:20-25.
26. Kohn EC, Alessandro R, Probst J, Jacobs W, Brilley E, Felder CC (1996): Identification and molecular characterization of a m5 muscarinic receptor in A2058 human melanoma cells. J Biol Chem 271:17476-17484.
27. Krnjevic K (1974): Chemical nature of synaptic transmission in vertebrates. Physiol Rev 54:418-540.
28. Kubo T, Fukuda K, Mikami A, Maeda A, Takahashi H, Mishina T, Haga K, Haga A, Ichiyama A, Kanagawa K, Kojima M, Matsuo H, Hirose T, Numa S (1986): Cloning, sequencing and expression of complimentary DNA encoding the muscarinic acetylcholine receptor. Nature 323:411-416.
29. Levey AI, Kitt CA, Simonds WF, Price DL, Brann MR (1991): Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies. J Neurosci 11:3216-3226.
30. Levey AI, Edmunds SM, Heilman CJ, Desmond TJ, Frey KA (1994): Localization of muscarinic m3 receptor protein and M3 receptor binding in rat brain. Neuroscience 63:207-221.
31. Levey AI, Edmunds SM, Koliatsos V, Wiley RG, Heilman CJ (1995): Expression of m1-m4 muscarinic acetylcholine receptor proteins in rat hippocampus and regulation by cholinergic innervation. J Neurosci 15:4077-4092.
32. Li M, Yasuda RP, Wall SJ, Wellstein A, Wolfe BB (1991): Distribution of m2 muscarinic receptors in rat brain using antisera selective for m2 receptors. Mol Pharmacol 40:28-35.
33. Maggio R, Barbier P, Bolognesi MK, Minarini A, Tedeschi D, Melchiorre C (1994): Binding profile of the selective muscarinic receptor antagonist tripitramine. Eur J Pharmacol 268:459-462.
34. Mak CWJ, Haddad E-B, Buckley NJ, Barnes PJ (1993): Visualization of muscarinic m4 mRNA and M4 receptor subtype in rabbit lung. Life Sci 53:1501-1508.
35. Maragos WF, Greenamyre JT, Penny JB, Young AB (1987): Glutamate dysfunction in Alzheimer's disease: a hypothesis. Trends Neurosci 10:55-68.
36. 3H]-dopamine release from dendrosomes of rat substantia nigra. Naunyn Schmiedebergs Arch Pharmacol 344:275-280.
37. Mash DC, Potter LT (1986): Autoradiographic localization of M1 and M2 muscarine receptors in the rat brain. Neuroscience 19:551-564.
38. Mash DC, Flynn DD, Potter LT (1985): Loss of M2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation. Science 228:1115-1117.
39. Max SI, Liang J-S, Potter LT (1993): Purification and properties of m1-toxin, a specific antagonist of m1 muscarinic receptors. J Neurosci 13:4293-4300.
40. McCormick DA, Prince DA (1985): Two subtypes of muscarinic responses to acetylcholine in mammalian cortical neurons. Proc Natl Acad Sci USA 82:6344-6348.
41. Mesulam M-M, Mufson EJ, Wainer BH, Levey AI (1983): Central cholinergic pathways in the rat: and overview based on an alternative nomenclature (Ch1-Ch6). Neurosci 10:1185-1201.
42. 3H]-4-DAMP. Eur J Pharmacol 166:459-466.
43. Paxinos G, Watson C (1986): The Rat Brain in Stereotaxic Coordinates, 2nd ed. New York: Academic Press.
44. Peralta EG, Winslow JW, Peterson GL, Smith DH, Ashkenazi A, Ramachandran J, Schimerlik MI, Capon DJ (1987): Primary structure and biochemical properties of a M2 muscarinic receptor. Science 236:600-605.
45. Potter LT, Purkerson SL (1995):Pharmacology of striatal cholinergic receptors. In Ariano MA, Surmeier DJ (eds): Molecular and Cellular Mechanisms of Neostriatal Function. RG Landes Co., Austin, TX, pp 241-254.
46. Raiteri M, Leardi R, Marchi M (1984): Heterogeneity of presynaptic muscarinic receptors regulating neurotransmitter release in the rat brain. J Pharmacol Exp Ther 228:209-214.
47. Raiteri M, Marchi M, Paudice P, Pittajuga A (1990): Muscarinic receptors mediating inhibition of-aminobutyric acid release in rat corpus striatum and their pharmacological characterization. J Pharmacol Exp Ther 254:496-501.
48. Rinken A (1995): Subtype-specific changes in ligand binding properties after solubilization of muscarinic receptors from baculovirus-infected SF9 insect cell membranes. J Pharmacol Exp Ther 272:8-14.
49. Rinken A, Kameyama K, Haga T, Engstrom L (1994): Solubilization of muscarinic receptor subtypes from baculovirus infected SF9 insect cells. Biochem Pharmacol 48:1245-1251.
50. Russo C, Marchi M, Andrioli GC, Cavazzani P, Raiteri M (1993): Enhancement of glycine release from human brain cortex synaptosomes by acetylcholine acting at M4 muscarinic receptors. J Pharmacol Exp Ther 266:142-146.
51. Spencer DG, Horvath E, Traber J (1986): Direct autoradiographic determination of M1 and M2 muscarinic acetylcholine receptor distribution in the rat brain: relation to cholinergic nuclei and projections. Brain Res 380:59-68.
52. Sugita S, Uchimura N, Jiang Z-G, North RA (1991): Distinct muscarinic receptors inhibit release of-aminobutyric acid and excitatory amino acids in mammalian brain. Proc Natl Acad Sci USA 88:2608-2611.
53. Thomas EA, Baker SA, Ehlert FJ (1993): Functional role for the M2 muscarinic receptor in smooth muscle of guinea-pig ileum. Mol Pharmacol 44:102-110.
54. Vilaro MT, Palacios JM, Mengod G (1990): Localization of m5 muscarinic receptor mRNA in rat brain examined by in situ hybridization histochemistry. Neurosci Lett 114:154-159.
55. Vilaro MT, Mengod G, Palacios JM (1993): Advances and limitations of the molecular neuroanatomy of cholinergic receptors: the example of multiple muscarinic receptors. Prog Brain Res 98:95-101.
56. Vilaro MT, Palacios JM, Mengod G (1994): Multiplicity of muscarinic autoreceptor subtypes? Comparison of the distribution of cholinergic cells and cells containing mRNA for five subtypes of muscarinic receptors in the rat brain. Mol Brain Res 21:30-46.
57. 3H]-N-methyl scopolamine binding to muscarinic receptors in the rat central nervous system: evidence for the existence of three classes of binding sites. Mol Pharmacol 30:305-314.
58. Waelbroeck M, Gillard M, Robberecht P, Christophe J (1987): Muscarinic receptor heterogeneity in the rat central nervous system. I. Binding of four selective antagonists to three muscarinic receptor subclasses: a comparison with M2 cardiac muscarinic receptors of die C type. Mol Pharmacol 32:91-99.
59. Waelbroeck M, Tastenoy M, Camus J, Christophe J (1990): Binding of selective antagonists to four muscarinic receptors (M1 to M4) in rat forebrain. Mol Pharmacol 38:267-273.
60. Wall SJ, Yasuda RP, Hory F, Flagg S, Martin BM, Ginns EI, Wolfe BB (1991a): Production of antisera selective for m1 muscarinic receptors using fusion proteins: distribution of m1 receptors in the rat brain. Mol Pharmacol 39:643-649.
61. Wall SJ, Yasuda RP, Li M, Wolfe BB (1991b): Development of an antiserum against m3 muscarinic receptors: distribution of m3 receptors in rat tissues and clonal cell lines. Mol Pharmacol 40:783-789.
62. Wang SZ, Zhu SZ, El-Fakahany EE (1994): Efficient coupling of m5 muscarinic acetylcholine receptors to activation of nitric oxide synthase. J Pharmacol Exp Ther 268:532-557.
63. Weiner DM, Levey AI, Brann MR (1990): Expression of muscarinic acetylcholine and dopamine receptor mRNA's in rat basal ganglia. Proc Natl Acad Sci USA 87:7050-7054.
64. Whitehouse PJ, Price DL, Struble RG, Clark AW Coyle JT, DeLong MR (1982): Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 215:1237-1240.
65. Yasuda RP, Ciesla W, Flores LR, Wall SJ, Li M, Satkus SA, Wesstein JS, Spagnola BV, Wolfe BB (1993): Development of antisera selective for m4 and m5 muscarinic cholinergic receptors: distribution of m4 and m5 receptors in rat brain. Mol Pharmacol 43:149-157.
66. Zubieta JK, Frey KA (1993): autoradiographic mapping of M3 muscarinic receptors in the rat brain. J Pharmacol Exp Ther 264:415-422.